COST is trading 40.1% above its estimated fair value, a level that flags significant overvaluation risk.
COST fair value assessment
COST is trading 40.1% above its estimated fair value, a level that flags significant overvaluation risk.
Reality vs. Belief
COST's narrative runs slightly ahead of its fundamentals, but stays within a defensible range.
COST signal snapshot
COST projected price & trade signal
What's driving COST's price
The story driving COST right now: Costco Wholesale is a superior long-term investment compared to Macy's due to its distinct membership-based business model, consistent growth in members and comparable sales, and ongoing warehouse expansion. High volatility-momentum readings (100) indicate significant narrative-driven price displacement.
Market Prism's verdict on COST
Market Prism classifies COST as Overvalued Stable — the price sits above what the narrative justifies, but the story isn't actively breaking down. Narrative energy is moderating at 53%, an early sign of fatigue.
Valuation outlook for COST
Overvalued-but-stable names can hold a premium for a while. The risk is asymmetric: limited upside, with a long way to fall if the story cracks. The 40.1% fair-value deviation is extreme and, historically, tends to revert within 30–60 trading days.
Frequently asked questions
Is COST overvalued right now?
COST is trading 40.1% above its estimated fair value, a level that flags significant overvaluation risk.
What is Market Prism's verdict on COST?
Market Prism classifies COST as Overvalued Stable — the price sits above what the narrative justifies, but the story isn't actively breaking down. Narrative energy is moderating at 53%, an early sign of fatigue.
What happens next for COST?
Overvalued-but-stable names can hold a premium for a while. The risk is asymmetric: limited upside, with a long way to fall if the story cracks. The 40.1% fair-value deviation is extreme and, historically, tends to revert within 30–60 trading days.
Is COST a good value investment?
Market Prism does not provide investment recommendations. Our forensic analysis shows: COST looks overvalued but stable, trading 40.1% above estimated fair value.